Literature DB >> 11707487

Community health risk assessment after a fire with asbestos containing fallout.

S Bridgman1.   

Abstract

BACKGROUND: A factory fire in Tranmere, Merseyside, England, deposited asbestos containing fallout in an urban area. There was considerable community anxiety for months after the incident. Therefore an assessment of the long term health risks of this acute environmental incident were requested by the local health authority.
METHODS: The facts of the incident were gathered and appraised from unpublished and press reports, involved personnel, and further analysis of material collected at the time of the incident. The literature on the long term health risks of asbestos was reviewed, and combined with evidence on asbestos exposure to estimate community health risk.
RESULTS: Risk was almost entirely from exposure to fire fallout of chrysotile in asbestos bitumen paper covering the factory roof. Amosite was only detected in a few samples and in trace amounts. The number of people who lived in the area of fallout was 16 000 to 48 000. From a non-threshold model with assumptions likely to overestimate risk, the lung cancer risk is estimated to be undetectably small. Risk of mesothelioma from chrysotile exposure, and risks of lung cancer and mesothelioma from amosite exposure were based on observational studies and were estimated to be even lower than that of lung cancer risk from chrysotile exposure. Academically, there are assumptions that while reasonable cannot be proven, for example, the validity of extrapolating observed risk from much higher exposures to lower exposures, estimates of individual exposure, and that there is no threshold for asbestos to cause cancer.
CONCLUSIONS: The author is unaware of a similar study on long term health risks in a community exposed to asbestos in a fire. It is concluded that, using methods that do not underestimate risk, risk is undetectably small. Practical lessons from this methodology and approach to health risk assessment are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11707487      PMCID: PMC1731804          DOI: 10.1136/jech.55.12.921

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  12 in total

1.  Acute health effects of a fire associated with asbestos-containing fallout.

Authors:  S A Bridgman
Journal:  J Public Health Med       Date:  2000-09

2.  Asbestos and cancer: history and public policy.

Authors:  W K Morgan
Journal:  Br J Ind Med       Date:  1992-06

Review 3.  Asbestos as a public health risk: disease and policy.

Authors:  H Weill; J M Hughes
Journal:  Annu Rev Public Health       Date:  1986       Impact factor: 21.981

4.  Short-term asbestos work exposure and long-term observation.

Authors:  H Seidman; I J Selikoff; E C Hammond
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

5.  Relationship of mortality to measures of environmental asbestos pollution in an asbestos textile factory.

Authors:  J Peto; R Doll; C Hermon; W Binns; R Clayton; T Goffe
Journal:  Ann Occup Hyg       Date:  1985

6.  Lessons learnt from a factory fire with asbestos-containing fallout.

Authors:  S A Bridgman
Journal:  J Public Health Med       Date:  1999-06

Review 7.  Contamination of the air with mineral fibers following the explosive destruction of buildings and fire.

Authors:  J A Hoskins; R C Brown
Journal:  Drug Metab Rev       Date:  1994       Impact factor: 4.518

8.  Human evidence: lung cancer mortality risk from chrysotile exposure.

Authors:  J M Hughes
Journal:  Ann Occup Hyg       Date:  1994-08

9.  Cancer in a factory using amosite asbestos.

Authors:  E D Acheson; M J Gardner; P D Winter; C Bennett
Journal:  Int J Epidemiol       Date:  1984-03       Impact factor: 7.196

10.  Asbestos in New York City public school buildings--public policy: is there a scientific basis?

Authors:  R Wilson; A M Langer; R P Nolan; J B Gee; M Ross
Journal:  Regul Toxicol Pharmacol       Date:  1994-10       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.